ArticleCellular and molecular life sciences : CMLS2022

Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells.

Ana Valeria Meléndez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.